Understanding Tyrosine Kinases in Schistosoma mansoni
Author Information
Author(s): Lívia G. A. Avelar, Laila A. Nahum, Luiza F. Andrade, Guilherme Oliveira
Primary Institution: Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz - FIOCRUZ
Hypothesis
The study investigates the functional diversity of tyrosine kinases in Schistosoma mansoni and their potential as drug targets.
Conclusion
Tyrosine kinases in Schistosoma mansoni are essential for the parasite's life cycle and represent promising targets for new anti-schistosomiasis drugs.
Supporting Evidence
- Over 200 million people are infected with Schistosoma mansoni worldwide.
- Tyrosine kinases play key roles in cellular processes and are potential targets for drug development.
- The study identifies 252 eukaryotic protein kinases in the Schistosoma mansoni genome.
Takeaway
This study looks at special proteins called tyrosine kinases in a parasite that makes people sick, and how they could help us find new medicines to treat the disease.
Methodology
The study reviews existing literature and genomic data to analyze the role of tyrosine kinases in Schistosoma mansoni.
Limitations
The genomic data of Schistosoma mansoni remains fragmented, which may lead to underestimations of certain protein families.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website